跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,401 条关于
“tumor-activated immuno-oncology”
全部
40,401
临床试验
26,108
药物
1,611
机构
343
资讯
12,339
去年
Xilio Therapeutics Strengthens Leadership Team with New Chief Legal Officer Amid Advancement of Tumor-Activated Immunotherapy Pipeline
2年前
Xilio Therapeutics Advances Tumor-Activated Immunotherapy Pipeline with Phase 2 Trial of XTX101 Set for Q3 2024
5个月前
GlycoNex Partners with Nippon Kayaku to Develop Tumor-Activated ADC GNX201 for Solid Tumors
2年前
MAIA Biotechnology Completes Enrollment in Phase 2 THIO-101 Trial for Advanced NSCLC
11年前
AstraZeneca Expands Immuno-Oncology Portfolio with Three Strategic Partnerships
7个月前
Bristol Myers Squibb Partners with Janux Therapeutics in $850M Tumor-Activated Cancer Drug Deal
6个月前
Voro Therapeutics Partners with Daiichi Sankyo to Develop Tumor-Activated ADCs Using PrimeBody Platform
10个月前
Accession Therapeutics Doses First Patient in Phase 1 Trial of Novel Tumor-Activated Viral Immunotherapy TROCEPT-01
去年
Syantra Launches Immuno-Oncology Therapeutic Division to Reverse Cancer-Related Immune Cell Corruption
去年
GIST and Genome & Company Identify CNTN4 as Novel Immuno-Oncology Target
第 1 页,共 1234 页
上一页
下一页